News posted in June 2011

Azellon is a spin-out from The University of Bristol focused on the R&D and commercialisation of an adult autologous (patient's own) stem cell technology for the repair of avascular meniscal tears.

Outstanding contributions to the commercialisation of university research were recognised  at the PraxisUnico Conference 2011 in Glasgow on 10 June.

Cambridge-based Lab21, which specialises in personalised medicine and clinical diagnostics, announced in May that it had acquired Myconostica, a molecular diagnostic company focusing on the diagnosis of fungal infections of clinical importance.

IP Group plc (LSE: IPO) has issued a Prospectus for a proposed placing and open offer of 110 million new ordinary shares at the issue price of 50 pence each.

The University of Strathclyde took the strategic decision to invest in EnviroCentre as a spin-out company in 1995, and the company has gone on to become one of Scotland’s leading environmental consultancies.

In May the company completed a seed funding round of equity investment led by Mercia Fund Management, and announced its participation in a £2.1 million project funded by the TSB, EPSRC, and industrial partners.

The Intellectual Property Office (IPO) launched in May a new strategy guide to help universities to develop and manage their intellectual assets.

Lumora, a molecular diagnostics company which is developing next generation tests through its proprietary BART Technology platform, completed in May a £1.5 million funding round, led by Catapult Venture Managers.

The SETsquared partnership has announced that one of the companies it has supported, Fitronics, has completed a successful sale of the business.